Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hayward

Showing results (171-180 of 394) with videos related to

Pageof 40
Sort By:
Schizophrenia Research|January 13, 2006
Cell cycle alterations in biopsied olfactory neuroepithelium in schizophrenia and bipolar I disorder using cell culture and gene expression analysesRichard D McCurdy, François Féron, Chris Perry, et al.
International Journal of Cancer|July 4, 2001
CDKN2A is not the principal target of deletions on the short arm of chromosome 9 in neuroendocrine (Merkel cell) carcinoma of the skinA L Cook, P M Pollock, J Welch, et al.
Melanoma Research|November 10, 2007
Expression of Wnt5a and its downstream effector beta-catenin in uveal melanomaWieke Zuidervaart, Sandra Pavey, Frans A van Nieuwpoort, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2010
High-risk human papillomavirus in esophageal squamous cell carcinomaAnnika Antonsson, Derek J Nancarrow, Ian S Brown, et al.
The European Respiratory Journal|July 3, 2007
Gene expression of lung squamous cell carcinoma reflects mode of lymph node involvementJ E Larsen, S J Pavey, R Bowman, et al.
International Journal of Cancer|April 5, 2008
Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinomaJames Doecke, Zhen Zhen Zhao, Nirmala Pandeya, et al.
Cancer Research|November 14, 1997
CDKN2A/p16 is inactivated in most melanoma cell linesM Castellano, P M Pollock, M K Walters, et al.
Human Molecular Genetics|October 1, 1995
Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindredsG J Walker, C J Hussussian, J F Flores, et al.
Oncotarget|June 23, 2016
The "melanoma-enriched" microRNA miR-4731-5p acts as a tumour suppressorMitchell S Stark, Lisa N Tom, Glen M Boyle, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2008
Single nucleotide polymorphisms in obesity-related genes and the risk of esophageal cancersJames D Doecke, Zhen Zhen Zhao, Mitchell S Stark, et al.
Pageof 40

Showing results (171-180 of 394) with videos related to

Sort By:
Pageof 40
Schizophrenia Research|January 13, 2006
Cell cycle alterations in biopsied olfactory neuroepithelium in schizophrenia and bipolar I disorder using cell culture and gene expression analysesRichard D McCurdy, François Féron, Chris Perry, et al.
International Journal of Cancer|July 4, 2001
CDKN2A is not the principal target of deletions on the short arm of chromosome 9 in neuroendocrine (Merkel cell) carcinoma of the skinA L Cook, P M Pollock, J Welch, et al.
Melanoma Research|November 10, 2007
Expression of Wnt5a and its downstream effector beta-catenin in uveal melanomaWieke Zuidervaart, Sandra Pavey, Frans A van Nieuwpoort, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2010
High-risk human papillomavirus in esophageal squamous cell carcinomaAnnika Antonsson, Derek J Nancarrow, Ian S Brown, et al.
The European Respiratory Journal|July 3, 2007
Gene expression of lung squamous cell carcinoma reflects mode of lymph node involvementJ E Larsen, S J Pavey, R Bowman, et al.
International Journal of Cancer|April 5, 2008
Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinomaJames Doecke, Zhen Zhen Zhao, Nirmala Pandeya, et al.
Cancer Research|November 14, 1997
CDKN2A/p16 is inactivated in most melanoma cell linesM Castellano, P M Pollock, M K Walters, et al.
Human Molecular Genetics|October 1, 1995
Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindredsG J Walker, C J Hussussian, J F Flores, et al.
Oncotarget|June 23, 2016
The "melanoma-enriched" microRNA miR-4731-5p acts as a tumour suppressorMitchell S Stark, Lisa N Tom, Glen M Boyle, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2008
Single nucleotide polymorphisms in obesity-related genes and the risk of esophageal cancersJames D Doecke, Zhen Zhen Zhao, Mitchell S Stark, et al.
Pageof 40